A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced

Salah-Eddine Bentebibel1, Michael E Hurwitz2, Chantale Bernatchez1

  • 1The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Discovery
|April 17, 2019
PubMed

Insights

NKTR-214 (bempegaldesleukin), an IL2 pathway agonist, demonstrated safety and clinical activity in a phase I study. It effectively activated immune cells and reduced tumors without expanding regulatory T cells.

Area of Science:

  • Oncology
  • Immunotherapy
  • Pharmacology

Background:

  • NKTR-214 (bempegaldesleukin) is a novel IL2 pathway agonist engineered for sustained IL2 receptor signaling.
  • It aims to enhance CD8+ T and natural killer cell activation while minimizing regulatory T cell (Treg) expansion in the tumor microenvironment.

Purpose of the Study:

  • To evaluate the safety, tolerability, and preliminary clinical activity of NKTR-214 in a first-in-human phase I study.
  • To determine the recommended Phase II dose (RP2D) for NKTR-214.

Main Methods:

  • A multicenter, first-in-human, phase I study of NKTR-214 administered in an outpatient setting.
  • Assessment of safety, pharmacodynamics (immune cell activation, Treg levels), and clinical activity (tumor response, disease stabilization) through peripheral blood analysis and on-treatment tumor biopsies.
  • Transcriptional analysis of tumor biopsies to evaluate IL2 pathway engagement and effector gene expression.

Main Results:

  • NKTR-214 was well tolerated and showed clinical activity, including tumor shrinkage and durable disease stabilization in heavily pretreated patients.
  • Observed immune activation and increased immune cell numbers in peripheral blood across all doses, with sustained activity upon repeated administration.
  • On-treatment biopsies confirmed NKTR-214 promoted immune cell increases with limited Treg expansion, and transcriptional analysis indicated IL2 pathway engagement and increased effector gene expression.

Conclusions:

  • NKTR-214 is a well-tolerated IL2 pathway agonist with demonstrated clinical activity and favorable immunomodulatory effects.
  • The recommended Phase II dose of NKTR-214 is 0.006 mg/kg every three weeks.
  • NKTR-214 shows promise as a key component in immunotherapy treatment algorithms, particularly in combination with agents like checkpoint inhibitors.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.3K
Confirmation Biases01:31

Confirmation Biases

The confirmation bias is the tendency to focus on information that confirms our existing beliefs and ignore information that is inconsistent with our expectations. For example, if you think that your professor is not very nice, you notice all of the instances of rude behavior exhibited by the professor while ignoring the countless pleasant interactions he is involved in on a daily basis. Have you ever fallen prey to the confirmation bias, either as the source or target of such bias?
8.1K
Hindsight Biases01:12

Hindsight Biases

Hindsight bias leads you to believe that the event you just experienced was predictable, even though it really wasn’t. In other words, you knew all along that things would turn out the way they did. Can you relate this to the phrase "Hindsight is 20/20" now? 
4.2K
Bias01:22

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
7.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
840
Sample Preparation for Analysis: Advanced Techniques01:08

Sample Preparation for Analysis: Advanced Techniques

Accurate analysis of complex samples often requires advanced preparation techniques to achieve reliable and reproducible results. Samples containing inorganic or organic materials can be challenging to dissolve or decompose effectively. Standard sample preparation methods include acid digestion, fusion, dry ashing, and wet digestion.
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
1.3K